JP2014519817A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014519817A5 JP2014519817A5 JP2014509577A JP2014509577A JP2014519817A5 JP 2014519817 A5 JP2014519817 A5 JP 2014519817A5 JP 2014509577 A JP2014509577 A JP 2014509577A JP 2014509577 A JP2014509577 A JP 2014509577A JP 2014519817 A5 JP2014519817 A5 JP 2014519817A5
- Authority
- JP
- Japan
- Prior art keywords
- ssrna
- vlp
- production method
- papmv
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 25
- 238000004519 manufacturing process Methods 0.000 claims 22
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims 17
- 241000709995 Papaya mosaic virus Species 0.000 claims 12
- 101710132601 Capsid protein Proteins 0.000 claims 8
- 101710094648 Coat protein Proteins 0.000 claims 8
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims 8
- 101710125418 Major capsid protein Proteins 0.000 claims 8
- 101710141454 Nucleoprotein Proteins 0.000 claims 8
- 101710083689 Probable capsid protein Proteins 0.000 claims 8
- 239000000427 antigen Substances 0.000 claims 7
- 102000036639 antigens Human genes 0.000 claims 7
- 108091007433 antigens Proteins 0.000 claims 7
- 239000002245 particle Substances 0.000 claims 7
- 241000710007 Potexvirus Species 0.000 claims 6
- 239000002773 nucleotide Substances 0.000 claims 6
- 125000003729 nucleotide group Chemical group 0.000 claims 6
- 102000004169 proteins and genes Human genes 0.000 claims 6
- 108090000623 proteins and genes Proteins 0.000 claims 6
- 108700030444 papaya mosiac virus coat Proteins 0.000 claims 5
- 239000000825 pharmaceutical preparation Substances 0.000 claims 5
- 229940127557 pharmaceutical product Drugs 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 4
- 238000000338 in vitro Methods 0.000 claims 4
- 230000000890 antigenic effect Effects 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 3
- 230000028993 immune response Effects 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 150000007523 nucleic acids Chemical group 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 101710163270 Nuclease Proteins 0.000 claims 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 2
- 239000013627 low molecular weight specie Substances 0.000 claims 2
- 241000712461 unidentified influenza virus Species 0.000 claims 2
- 108020004705 Codon Proteins 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 230000028996 humoral immune response Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000015788 innate immune response Effects 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 230000016379 mucosal immune response Effects 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161485955P | 2011-05-13 | 2011-05-13 | |
| US61/485,955 | 2011-05-13 | ||
| PCT/CA2012/050279 WO2012155262A1 (en) | 2011-05-13 | 2012-05-01 | Virus-like particles and process for preparing same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014519817A JP2014519817A (ja) | 2014-08-21 |
| JP2014519817A5 true JP2014519817A5 (enExample) | 2015-06-25 |
| JP6213461B2 JP6213461B2 (ja) | 2017-10-18 |
Family
ID=47176093
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014509577A Expired - Fee Related JP6213461B2 (ja) | 2011-05-13 | 2012-05-01 | ウイルス様粒子およびその調製プロセス |
| JP2014509576A Expired - Fee Related JP6093926B2 (ja) | 2011-05-13 | 2012-05-01 | パパイヤモザイクウイルス組成物および自然免疫応答刺激のためのその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014509576A Expired - Fee Related JP6093926B2 (ja) | 2011-05-13 | 2012-05-01 | パパイヤモザイクウイルス組成物および自然免疫応答刺激のためのその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9833504B2 (enExample) |
| EP (2) | EP2707480B1 (enExample) |
| JP (2) | JP6213461B2 (enExample) |
| CN (2) | CN103648528A (enExample) |
| AU (1) | AU2012255595A1 (enExample) |
| BR (2) | BR112013029143A2 (enExample) |
| CA (2) | CA2835972A1 (enExample) |
| DK (1) | DK2707480T3 (enExample) |
| MX (1) | MX2013013228A (enExample) |
| NO (1) | NO2800866T3 (enExample) |
| WO (2) | WO2012155262A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2707480T3 (da) | 2011-05-13 | 2017-11-13 | Folia Biotech Inc | Viruslignende partikler og fremgangsmåde til fremstilling heraf |
| US20160228541A1 (en) * | 2013-09-19 | 2016-08-11 | Alain Lamarre | Papaya mosaic virus and virus-like particles in cancer therapy |
| US11998594B2 (en) | 2014-04-02 | 2024-06-04 | Case Western Reserve University | Anti-cancer plant virus particles linked to HER2 antigens |
| US10098936B2 (en) | 2014-04-02 | 2018-10-16 | Case Western Reserve University | Vaccination using plant virus particles linked to HER2 antigens |
| CN107002085A (zh) * | 2014-09-11 | 2017-08-01 | 卡迪拉保健有限公司 | 具有优异免疫学特性的优异的人乳头瘤病毒抗原和含有其的疫苗 |
| WO2016127262A1 (en) * | 2015-02-12 | 2016-08-18 | Folia Biotech Inc. | Multimerized orthomyxovirus nucleoprotein and uses thereof |
| GB201708709D0 (en) | 2017-06-01 | 2017-07-19 | Univ York | Virus like particle |
| MX385484B (es) * | 2017-06-28 | 2025-03-14 | Univ Mexico Nac Autonoma | Vlps derivadas de virus de planta con dsrna encapsidado y metodo de sintesis. |
| FR3106648B1 (fr) * | 2020-01-28 | 2022-05-27 | Arkema France | Structure multicouche pour le transport ou le stockage de l’hydrogene |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5443969A (en) | 1992-10-29 | 1995-08-22 | Rutgers University | RNA packaging system |
| US8101189B2 (en) | 2002-07-05 | 2012-01-24 | Folia Biotech Inc. | Vaccines and immunopotentiating compositions and methods for making and using them |
| CA2434000C (en) * | 2002-07-05 | 2012-07-17 | Denis Leclerc | Adjuvant viral particle |
| CN100404070C (zh) | 2003-07-10 | 2008-07-23 | 赛托斯生物技术公司 | 包装的病毒样颗粒 |
| ES2615169T3 (es) | 2003-10-22 | 2017-06-05 | Id Biomedical Corporation Of Quebec | Composiciones y procedimientos de activación de la inmunidad innata y alérgica |
| WO2008058369A1 (en) | 2006-11-15 | 2008-05-22 | Folia Biotech Inc. | Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| CA2669485C (en) | 2006-11-15 | 2017-01-03 | Folia Biotech Inc. | Papaya mosaic virus-based vaccines for influenza |
| US7799281B2 (en) | 2007-01-16 | 2010-09-21 | Festo Corporation | Flux concentrator for biomagnetic particle transfer device |
| CA2676481A1 (en) | 2007-01-26 | 2008-07-31 | Folia Biotech Inc. | Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| WO2010012069A1 (en) | 2008-07-30 | 2010-02-04 | Folio Biotech Inc. | Multivalent vaccines based on papaya mosaic virus and uses thereof |
| WO2010030790A2 (en) | 2008-09-10 | 2010-03-18 | The Texas A&M University System | Methods and compositions for stimulation of mammalian innate immune resistance to pathogens |
| DK2707480T3 (da) | 2011-05-13 | 2017-11-13 | Folia Biotech Inc | Viruslignende partikler og fremgangsmåde til fremstilling heraf |
-
2012
- 2012-05-01 DK DK12785518.7T patent/DK2707480T3/da active
- 2012-05-01 AU AU2012255595A patent/AU2012255595A1/en not_active Abandoned
- 2012-05-01 JP JP2014509577A patent/JP6213461B2/ja not_active Expired - Fee Related
- 2012-05-01 WO PCT/CA2012/050279 patent/WO2012155262A1/en not_active Ceased
- 2012-05-01 CA CA2835972A patent/CA2835972A1/en not_active Abandoned
- 2012-05-01 CN CN201280023824.XA patent/CN103648528A/zh active Pending
- 2012-05-01 JP JP2014509576A patent/JP6093926B2/ja not_active Expired - Fee Related
- 2012-05-01 BR BR112013029143A patent/BR112013029143A2/pt not_active IP Right Cessation
- 2012-05-01 EP EP12785518.7A patent/EP2707480B1/en not_active Not-in-force
- 2012-05-01 BR BR112013029144A patent/BR112013029144A2/pt not_active IP Right Cessation
- 2012-05-01 US US14/117,365 patent/US9833504B2/en active Active
- 2012-05-01 CN CN201280022947.1A patent/CN103687942A/zh active Pending
- 2012-05-01 MX MX2013013228A patent/MX2013013228A/es not_active Application Discontinuation
- 2012-05-01 EP EP12786315.7A patent/EP2707027A4/en not_active Withdrawn
- 2012-05-01 WO PCT/CA2012/050278 patent/WO2012155261A1/en not_active Ceased
- 2012-05-01 CA CA2835967A patent/CA2835967A1/en not_active Abandoned
- 2012-05-01 US US14/117,363 patent/US20140154288A1/en not_active Abandoned
-
2013
- 2013-01-04 NO NO13700794A patent/NO2800866T3/no unknown